论文部分内容阅读
打造具有核心竞争力的医药健康整体服务商国药控股湖南有限公司是中央企业中国医药集团在湘大型国有企业。中国医药集团位列《财富》世界500强排行榜单第276位,是惟一上榜中国医药企业。公司自2004年成立以来,年综合经营指标以50%的速度递增,实现了10年增长50倍的超常规发展,销售及利税规模居于全国医药商业企业前50强。公司作为湖南省人民政府与中国医药集团签署《战略合作协议》的履约方与运营平台,全力构建湖南省药品
To build a core competitiveness of the overall medical and health service provider Sinopharm Hunan Co., Ltd. is the central state-owned Chinese medicine group in Hunan large-scale state-owned enterprises. China National Pharmaceutical Group is ranked 276th in the Fortune Global 500 list and is the only Chinese pharmaceutical company listed on the list. Since the establishment of the company in 2004, the annual comprehensive management index has risen by 50%, achieving a 50-fold increase over the past 10 years in unconventional development. The sales and profit-tax scale ranks the top 50 in the national pharmaceutical commercial enterprises. The Company, as the performing party and operation platform of the “Strategic Cooperation Agreement” signed between Hunan Provincial People’s Government and China National Pharmaceutical Group, tries its best to build the pharmaceutical products of Hunan Province